1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Medicenna Therapeutics Corp.
  6. News
  7. Summary
    MDNA   CA58490H1073

MEDICENNA THERAPEUTICS CORP.

(MDNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Medicenna Therapeutics up 12.7% in US Trade, Details Management Change, Appoints Development Advisory Committee

01/18/2022 | 07:07am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMGEN INC. 0.37% 246.195 Delayed Quote.9.06%
MEDICENNA THERAPEUTICS CORP. 0.72% 1.4 Delayed Quote.-33.81%
NOVARTIS AG 0.11% 87.51 Delayed Quote.8.88%
ON SEMICONDUCTOR CORPORATION -0.89% 57.97 Delayed Quote.-13.87%
All news about MEDICENNA THERAPEUTICS CORP.
05/11Medicenna Presents Phase 1/2 ABILITY Data Highlighting MDNA11's "Favorable" Clinical Pr..
MT
05/11Medicenna Therapeutics Corp. Presents Phase 1/2 Ability Study Data Highlighting Mdna11'..
CI
05/11Medicenna Presents Phase 1/2 ABILITY Study Data Highlighting MDNA11's Favorable Clinica..
AQ
05/02Medicenna up 7.3% in US Pre-Market as Details Promising New Clinical Data From Phase 1/..
MT
05/02MEDICENNA THERAPEUTICS : Announces New Clinical Data Showing Dose-Dependent Stimulation of..
PU
05/02Medicenna Announces New Clinical Data Showing Dose-Dependent Stimulation of Anti-Cancer..
AQ
05/02Medicenna Therapeutics Corp. Announces New Clinical Data Showing Dose-Dependent Stimula..
CI
04/27MEDICENNA THERAPEUTICS : to Present at the 2022 Bloom Burton & Co. Healthcare Investor Con..
PU
04/27Medicenna Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Co..
AQ
04/08Medicenna Presents Preclinical Data Showing Anti-Cancer Activity at the AACR Annual Mee..
MT
More news
Analyst Recommendations on MEDICENNA THERAPEUTICS CORP.
More recommendations
Financials
Sales 2022 - - -
Net income 2022 -25,1 M -19,6 M -19,6 M
Net Debt 2022 - - -
P/E ratio 2022 -2,99x
Yield 2022 -
Capitalization 77,2 M 60,2 M 60,2 M
Capi. / Sales 2022 -
Capi. / Sales 2023 53,7x
Nbr of Employees 13
Free-Float 66,9%
Chart MEDICENNA THERAPEUTICS CORP.
Duration : Period :
Medicenna Therapeutics Corp. Technical Analysis Chart | MDNA | CA58490H1073 | MarketScreener
Technical analysis trends MEDICENNA THERAPEUTICS CORP.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 1,39 CAD
Average target price 11,48 CAD
Spread / Average Target 726%
EPS Revisions
Managers and Directors
Fahar Merchant Chairman, President & Chief Executive Officer
Elizabeth Williams Chief Financial Officer & Secretary
Martin Bexon Chief Medical Officer
Albert George Beraldo Independent Non-Executive Director
Chandrakant J. Panchal Lead Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDICENNA THERAPEUTICS CORP.-33.81%60
MODERNA, INC.-43.98%56 593
LONZA GROUP AG-27.42%41 313
IQVIA HOLDINGS INC.-26.74%39 122
SEAGEN INC.-5.21%26 976
ICON PUBLIC LIMITED COMPANY-32.47%17 002